Jury says Johnson & Johnson must pay RM33bil in case over male breast growth linked to Risperdal – The Star Online
- Jury says Johnson & Johnson must pay RM33bil in case over male breast growth linked to Risperdal The Star Online
- Johnson & Johnson must pay $8 billion over drug side effect: jury New Straits Times
- Man wins $8 billion from J&J over claims drug gave him breasts Business Insider
- Johnson & Johnson, Risperdal maker hit with $8B verdict Oklahoman.com
- Johnson & Johnson must pay $8 bn over drug side effect: jury Bangkok Post
- View full coverage on Google News
Source: Business News Feed